Alimentary Tract| Volume 35, ISSUE 9, P635-641, September 2003

Glutathione supplementation improves oxidative damage in experimental colitis


      Background. The pathogenesis of inflammatory bowel disease is due, in part, to enhanced free-radical production and reduced antioxidant potential in mucosa cells.
      Aim. We evaluated in a rat model of trinitrobenzensulphonic acid (TNBS) colitis to see whether parenteral administration of glutathione is able to improve mucosal oxidative damage at onset (study A) and during chronic phases of colitis (study B).
      Methods. In study A, the rats were injected with a single dose of glutathione (200 mg/kg, i.p.) or saline (0,2 ml, i.p.) 1 h before colitis induction and killed 1 h later. In study B, rats with induced colitis were treated with daily injection of glutathione (50 mg/kg, i.p.) or saline (0,2 ml, i.p.), and killed at 1, 2, 4 and 8 weeks. We evaluated on mucosal samples the macroscopic and histological damage and the oxidative stress assessed by the mucosal levels of lipoperoxides, malonyldialdehyde, glutathione and cysteine.
      Results. In study A, colitis induction caused a significant increase to the total histological score (p<0.05), lipoperoxide and malonyldialdehyde levels (p<0.001), but did not affect glutathione and cysteine content. Glutathione pre-treatment decreased both total histological score (p<0.05) and lipoperoxide and malonyldialdehyde values (p<0.001). In study B, the extensive macroscopic and histological colonic damage induced by TNBS was accompanied by a reduction of glutathione and cysteine mucosal levels (p<0.01) and increased lipid peroxidation. Glutathione supplementation significantly improved colonic damage (p<0.01), restored glutathione and cysteine levels, and decreased, and even, if not totally, abolished lipid peroxidation (p<0.001).
      Conclusion. This paper further supports the pathogenic role of the imbalance in oxidant/antioxidant content in inducing mucosal colonic damage.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lih-Brody L.
        • Powell S.R.
        • Collier K.P.
        • Reddy G.M.
        • Cerchia R.
        • Kahn E.
        • et al.
        Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.
        Dig Dis Sci. 1996; 41: 2078-2086
        • Beno I.
        • Staruchova M.
        • Volkovova K.
        Ulcerative colitis: activity of antioxidant enzymes of the colonic mucosa.
        Press Med. 1997; 26: 1474-1477
        • Kimura H.
        • Hokari R.
        • Miura S.
        • Shigematsu T.
        • Hirokawa M.
        • Akiba Y.
        • et al.
        Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.
        Gut. 1998; 42: 180-187
        • Durak I.
        • Yasa M.H.
        • Bektas A.
        • Kacmaz M.
        • Cimen M.Y.
        • Ozturk H.S.
        Mucosal antioxidant defense is not impaired in ulcerative colitis.
        Hepatogastroenterology. 2000; 47: 1015-1017
        • Kruidenier L.
        • Verspaget H.W.
        Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease—radicals or ridiculous?.
        Aliment Pharmacol Ther. 2002; 16: 1997-2015
        • Sido B.
        • Hack V.
        • Hochlehner A.
        • Lipps H.
        • Herfarth C.
        • Droge W.
        Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.
        Gut. 1998; 42: 485-492
        • Reimund J.M.
        • Allison Ac.
        • Muller Cd.
        • Dumont S.
        • Kenney J.S.
        • Baumann R.
        • et al.
        Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn’s disease and ulcerative colitis.
        Eur J Clin Invest. 1998; 28: 145-150
        • Nieto N.
        • Fernandez M.I.
        • Torres M.I.
        • Rios A.
        • Suarez M.D.
        • Gil A.
        Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid.
        Dig Dis Sci. 1998; 43: 2676-2687
        • Cermak R.
        • Follmer U.
        • Wolffram S.
        Dietary flavonol quercetin induces chloride secretion in rat colon.
        Am J Physiol. 1998; 275: G1166-G1172
        • Loguercio C.
        • Di Pierro M.
        The role of glutathione in the gastrointestinal tract: a review.
        Ital J Gastroenterol Hepatol. 1999; 31: 401-407
        • Ardite E.
        • Sans M.
        • Panes J.
        • Romero F.J.
        • Pique J.M.
        • Fernandez-Checa J.C.
        Replenishement of glutathione levels improves mucosal function in experimental colitis.
        Lab Invest. 2000; 80: 735-744
        • Loguercio C.
        • D’Argenio G.
        • Delle Cave M.
        • Cosenza V.
        • Della Valle N.
        • Mazzacca G.
        • et al.
        Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.
        Dig Dis Sci. 1996; 41: 1204-1211
        • Koch T.R.
        • Yuan L.X.
        • Stryker S.J.
        • Ratliff P.
        • Telford G.L.
        • Opara E.C.
        Total antioxidant capacity of colon in patients with chronic ulcerative colitis.
        Dig Dis Sci. 2000; 45: 1814-1819
        • Aruoma O.I.
        • Halliwell B.
        • Hoey B.M.
        • Butler J.
        The antioxidant action of N-acetyl-cysteine: its reaction with hydrogen peroxide, hydroxylic radical, superoxide and hypoclorous acid.
        Free Radic Biol Med. 1989; 6: 593-597
        • Clerici C.
        • Gentili G.
        • Pellicciari R.
        • Gresele P.
        • Mezzasoma A.M.
        • Giansanti M.
        • et al.
        5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.
        Ital J Gastroenterol Hepatol. 1998; 30: 385-390
        • Simmonds N.J.
        • Millar A.D.
        • Blake D.R.
        • Rampton D.S.
        Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies.
        Aliment Pharmacol Ther. 1999; 13: 363-372
        • Meister A.
        Functions of glutathione.
        in: Larsson A. Orrenius S. Halmgreen A. Mannervick B. Functions of glutathione: biochemical, physiological, toxicological and clinical aspects. Raven Press, New York1983: 457-472
        • Loguercio C.
        • Taranto D.
        • Beneduce F.
        • Romano M.
        • Del Vecchio Blanco C.
        • De Vincentis A.
        • et al.
        Glutathione prevents ethanol-induced gastric mucosal damage and depletion of sulphydryl compounds in humans.
        Gut. 1993; 34: 161-165
        • D’Argenio G.
        • Cosenza V.
        • Sorrentini I.
        • De Ritis F.
        • Gatto A.
        • Delle Cave M.
        • et al.
        Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
        Gastroenterology. 1994; 106: 399-404
        • Blau S.
        • Kohen R.
        • Bass P.
        • Rubinstein A.
        Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis.
        Dig Dis Sci. 2000; 45: 1180-1187
        • Nieto N.
        • Torres M.I.
        • Fernandez M.I.
        • Giron M.D.
        • Rios A.
        • Suarez M.D.
        • et al.
        Experimental colitis impairs antioxidant defense system in rat intestine.
        Dig Dis Sci. 2000; 45: 1820-1827
        • Martensson J.
        • Jain A.
        • Meister A.
        Glutathione is required for intestinal function.
        Proc Natl Acad Sci. 1990; 87: 1715-1719
        • Holmes E.W.
        • Yong S.L.
        • Eiznhamer D.
        • Keshavarzian A.
        Glutathione content of colonic mucosa.
        Evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci. 1998; 43: 1088-1095
        • Roediger W.E.W.
        • Moore J.
        • Babidge W.
        Colonic sulfide in pathogenesis and treatment of ulcerative colitis.
        Dig Dis Sci. 1997; 42: 1571-1579
        • Leishout E.M.
        • Posner G.H.
        • Woodard B.T.
        • Peters W.H.
        Effects of the sulforaphane analog compound 30, indole-3-carbinol, d-limonene or relafen on glutathione S-transferases and glutathione peroxidase of the rat digestive tract.
        Biochim Biophys Acta. 1998; 1379: 325-336
        • Galvez J.
        • Coelho G.
        • Crespo M.E.
        • Cruz T.
        • Rodriguez-Cabezas M.E.
        • Concha A.
        • et al.
        Intestinal antinflammatory activity of morin on chronic experimental colitis in the rat.
        Aliment Pharmacol Ther. 2001; 15: 2027-2039